Hematology

SRI has extensive expertise in hematology, particularly in blood disorders and related oncology areas. Key diseases include Acute and Chronic Myeloid Leukemia (AML, CML), Myelodysplastic Syndromes (MDS), Multiple Myeloma, and Non-Hodgkin’s Lymphoma (including DLBCL and MCL). Our expertise also spans related disease areas requiring stem cell transplants and various cancer-related conditions, such as anemia and febrile neutropenia.

SRI conducts a wide spectrum of research, including demand estimation, forecasting, physician segmentation, big data analytics, market mapping, payor analytics, launch monitoring, message testing, and qualitative studies. OUR engagements involve interactions with diverse stakeholders, including physicians, nurses, pharmacists, patients, caregivers, and non-medical personnel across global markets. This comprehensive approach supports strategic decision-making throughout the product lifecycle in the hematology and blood disorder space.